TRIPLE-1/FUJITSU
18.3.2019 16:02:06 CET | Business Wire | Press release
TRIPLE-1, Inc. (Representative Director: Takuya Yamaguchi) and Fujitsu Electronics Inc. (Representative Director: Junji Ogihara) have entered into a distributorship contract for a mining ASIC (application specific IC) “KAMIKAZE” that uses the world's most advanced 7nm process technology.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190318005034/en/
--- Background:
In the development market for mining ICs, which requires huge computing power and high power efficiency, the introduction of advanced process technology has been attempted positively and just like the development market for ICs for smartphones, which is one of the world's leading manufacture industries, the driving force for development came from the process miniaturization in the advanced semiconductor industry. As of 2019, there is a mover away from the mainstream 16nm process which had been the oligopoly of traditional Chinese region manufacturers to the state-of-the-art 7nm process. In the past, several companies, including Japanese companies, announced their entry into cutting-edge 7nm process development, but at the moment there are only a handful of manufacturers that have succeeded in commercializing ASIC (application specific IC).
--- Purpose / Perspective:
TRIPLE-1 is a semiconductor system development company established in
November 2016 and specializing in cutting-edge process technology.
Since
February 2017, we began to develop the ASIC (application specific IC)
"KAMIKAZE" for bitcoin mining adopting the world's most advanced 7nm
process technology.
About a year later in February 2018, we
announced the world's first tape-out (design completion) in the
state-of-the-art 7nm process for the same application and proceeded with
commercialization by TSMC (Taiwan), the world's largest foundry.
Currently
TRIPLE-1 is the only manufacturer of ASIC (application specific IC) that
adopts the state-of-the-art 7nm process technology in Japan and is the
only Japanese company that confronts the world in the cutting-edge
process development market.
Fujitsu Electronics develops a wide
range of products from various brands and manufacturers for markets
around the world by making full use of the global network spreading both
in Japan and abroad, centered on the "Fujitsu brand" that has continued
to be trusted for many years around the world.
Through the signing
of this distributorship contract, we will be able to spread the global
development potential of Fujitsu Electronics and the state-of-the-art
process development capabilities of TRIPLE-1 all over the world and
provide the real value of “Japanese manufacturing” to markets around the
world. On top of that, by establishing a long-term and strong
partnership, we will cooperate not only in mining ASIC (application
specific IC), but also in the development and deployment of leading-edge
products for various fields and applications.
--- TRIPLE-1 “KAMIKAZE” Product Features:
1. Adopts the world's most advanced 7nm process technology
Develops
the world's first "KAMIKAZE", an ASIC (application specific IC) for
bitcoin mining with using world's Leading-Edge company TSMC (Taiwan) ’s
7nm process technology and evaluates the first tape out (first
generation) version, Power Efficiency: 52 J / TH was realized (measured
on September 26, 2018).
2. Reduced energy consumption that contributes to energy resource
conservation
By operating at ultra-low voltage (0.3V or less)
and achieving low power consumption, it is possible to contribute to the
reduction of the enormous power required for mining and energy resource
conservation while maintaining a high performance.
3. High cooling efficiency from changes in packaging
In
order to achieve higher cooling efficiency, we adopted a structure
(exposed die - FCBGA) in which the backside of the silicon chip is
exposed on the package to achieve higher cooling efficiency, chip size
was encapsulated in 7 mm × 7 mm.
--- TRIPLE-1 outline:
Company Name: TRIPLE-1, Inc.
Corporate Headquarter:
7F IT
Bldg.Ⅱ,1-14-20 Hakataeki-Higashi, Hakata-ku Fukuoka-shi, Fukuoka, Japan
Representatives:
Representative Director CEO Takuya Yamaguchi
The capital: 3662
million 895 thousand and 398 yen (including the capital reserve)
--- Features of Fujitsu Electronics:
As an "Electronics General Trading Company" that contributes to the development of customers' businesses through offering an extensive lineup of Fujitsu brand products centered on LSIs with leading-edge technology and proprietary products, as well as domestic and overseas manufacturer products, with comprehensive support including sales, technology, solution services, logistic services and more. With 13 locations in Japan and 20 locations overseas, we have established a global distributor system that can propose a wide range of solutions, building a consistent network that can respond to customer requests in a timely manner, from product procurement to development and mass production.
--- Fujitsu Electronics outline:
Company Name: Fujitsu Electronics Inc.
Corporate Headquarter:
2-100-45,
Shin-Yokohama, Kohoku-Ku, Yokohama-shi, Kanagawa, Japan
Representatives:
President and Representative Director Junji Ogihara
The capital:
4,877,683,581 yen
Website: http://www.fujitsu.com/jp/fei/en/
--- About the trademark:
Proper nouns such as the product names listed are trademarks or registered trademarks of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190318005034/en/
Contact:
Regarding this Press Release: TRIPLE-1, Inc. Public Relations Office GAKU MATSUSHIMA info@triple-1.com
Regarding Sales and Products: Fujitsu Electronics Inc. fei-triple1@dl.jp.fujitsu.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SamanTree Medical’s Histolog® Scanner Technology Featured in 13 Publications in Special BJU International Issue on Confocal Microscopy in Urology1.7.2026 15:01:00 CEST | Press release
Papers highlight clinical research on use of confocal microscopy for real-time tissue assessment in various urologic procedures SamanTree Medical, a global leader in surgical imaging innovation, today announced that Histolog Scanner confocal microscopy technology has been featured in 13 peer-reviewed clinical papers in a special issue of BJU International, one of the world’s leading journals in urology. The special edition focuses on a growing body of evidence of the role of confocal microscopy in urologic surgery. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260701425845/en/ SamanTree Medical announces that Histolog® Scanner confocal microscopy technology is featured in 13 peer-reviewed clinical papers in a special issue of BJU International. “The special issue represents increasing momentum behind confocal microscopy in urologic surgery,” said Professor Greg Shaw, consultant urologic surgeon at University College London
Regnology to Acquire Fed Reporter, Accelerating U.S. Leadership and Advancing Regulatory Modernization1.7.2026 15:00:00 CEST | Press release
Deal establishes Regnology as a central partner in U.S. regulatory modernization, extending reach to over 4,000 financial institutions Regnology, a leading provider at the intersection of regulatory, risk, and supervisory technology, today announced it has entered into a definitive agreement to acquire Fed Reporter, the market-leading U.S. provider of regulatory reporting solutions for financial institutions of all sizes, including banks, credit unions, and bank holding companies. The acquisition marks a pivotal milestone in Regnology’s U.S. expansion, creating the most comprehensive regulatory reporting coverage across the American financial landscape and extending its reach to more than 4,000 institutions from global banks to community lenders. By combining a proven, cloud-first, agentic-first technology foundation with deeply embedded local expertise, Regnology is uniquely positioned to support more efficient, transparent, and data-driven reporting, while strengthening alignment bet
Xsolla Announces Scholarship Program to Support Emerging Developers1.7.2026 15:00:00 CEST | Press release
New Initiative Expands Access To Gamescom By Reducing Financial Barriers For Independent And Mid-Tier Game Developers Worldwide Xsolla, a leading global video game commerce company, today announced the launch of the Xsolla Developer Scholarship Program - Cologne 2026 an initiative designed to support independent and mid-tier game developers who face financial barriers to attending gamescom 2026 in Cologne, Germany. As the world’s largest gaming event, gamescom brings together developers, publishers, investors, and industry leaders from across the globe to explore new opportunities, showcase innovative projects, and build meaningful business relationships. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260701200418/en/ Graphic: Xsolla The developer scholarship program is designed to help promising studios and independent creators gain access to one of the industry’s most influential events by providing professional developmen
AGC Pharma Chemicals Validates Facilities for CDMO Services via Scientist.com’s VERIF.i® Program1.7.2026 13:55:00 CEST | Press release
Scientist.com, the life sciences industry’s leading AI-enabled R&D orchestration platform and digital marketplace, and AGC Pharma Chemicals, a leading global Contract Development and Manufacturing Organization (CDMO) for small molecule API and HPAPI, announced today that AGC has successfully completed an onsite assessment of its new Barcelona facility using the VERIF.i® supplier pre-assessment program. The newly expanded Barcelona site strengthens AGC’s position as a global leader in the development and commercialization of complex small molecule Active Pharmaceutical Ingredients (APIs) and highly potent APIs (HPAPIs). Designed for maximum flexibility, safety, and energy efficiency, the facility expands AGC’s end-to-end capabilities from gram-scale to ton-scale production under the highest quality and sustainability standards. “At AGC Pharma Chemicals, we place the highest priority on the integrity of our operational processes and the expertise of our frontline teams,” said Jun Kurihar
Introducing Arbex: a New Global Leader in Tissue and Hygiene1.7.2026 13:37:00 CEST | Press release
$3.4 billion joint venture between Suzano and Kimberly-Clark launches independent operations and reveals key corporate details Upon launch, Arbex becomes one of the world’s largest tissue and hygiene businesses, operating across more than 70 markets on five continents, with its headquarters in the Netherlands and an operational office in London. The company will produce and sell leading global and regional brands including Kleenex®, Scott®, Cottonelle®, Andrex®, and Viva®, with 22 manufacturing sites in 14 countries. Ehab Abou-Oaf, previously President of International Family Care & Professional at Kimberly-Clark, will directly transition in as Arbex’s CEO, with the role to be based in the United Kingdom alongside the majority of the global executive team. Arbex, a new global leader in tissue and hygiene, today commences operations as an independent business and unveils details of its brand, leadership team, and company structure. Announced in June 2025 as a $3.4 billion joint venture
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
